Elevance Health (ELV) Stock Analysis & Winston Score
Elevance Health is one of the largest health insurance companies in the United States. It sells medical, dental, and vision insurance plans to individuals, families, employers, and government programs like Medicaid and Medicare. The company operates the Blue Cross Blue Shield brand in 14 states, which is one of the most recognized names in American healthcare. Elevance makes money by collecting monthly premiums from members and then paying out claims when those members use medical services. It serves roughly 45 million members across all 50 states, though its core insurance business is concentrated in states where it holds Blue Cross Blue Shield licenses. The company also runs a growing healthcare services segment called Carelon, which provides pharmacy, behavioral health, and care management services. The main risk Elevance faces is rising medical costs — when members use more healthcare than expected, profit margins shrink quickly, as seen in recent quarters where higher utilization pressured earnings.
Winston Score: 35/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (5/30)
- Growth: Mixed (6/20)
- Cash Flow: Strong (7/10)
- Stability: Good (6/10)
- Valuation: Mixed (4/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $373.11
Market Cap: $80.9B
Sector: Healthcare
Industry: Medical - Healthcare Plans


